AI Model for Classifying Breast Cancer From Histopathology Images
Recruiting now
Conditions studied: Breast Cancer
In brief
Breast cancer, a prevalent and potentially fatal disease, underscores the need for early and accurate detection to improve patient outcomes. Traditional histopathological examination, the current gold standard for diagnosis, faces limitations like subjectivity and low efficiency. In response, this research seeks to revolutionize breast cancer diagnostics by using deep learning techniques to classify invasive and noninvasive breast cancer types from histopathological images. Non-invasive cancers, like DCIS and LCIS, are confined to milk ducts or lobules, while invasive cancers spread to surrounding tissue and make up 70% of cases, often leading to poorer outcomes. The proposed AI model aims to enhance diagnostic accuracy and efficiency, surpassing manual methods, and providing a scalable solution for diverse healthcare settings. By automating image analysis, the model seeks to democratize cancer screening, making it accessible in underserved populations and adaptable to different resources and equipment. Ultimately, this research aims to advance breast cancer detection, improve patient care, and contribute to better treatment outcomes globally.
Key facts
- Study ID
- NCT06717984
- Run by
- Taufiq Hasan, PhD
- People needed
- 500
- Starts
- 2024-01-11
- Expected to finish
- 2025-02-11
- Last updated by the study team
- 2024-12-05
Who can join
Age: any. Sex: female. Healthy volunteers: accepted.
Where it is running
- National Institute of Cancer Research & Hospital (NICRH) — Dhaka, Bangladesh (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.